Compounds > nylidrin
Page last updated: 2024-11-01

nylidrin and Dermatitis Medicamentosa

nylidrin has been researched along with Dermatitis Medicamentosa in 3 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pevny, I1
Alomar, A1
Spindler, E1
Janier, M1
Bonnin, JM1
Carlotti, A1
Daniel, F1

Other Studies

3 other studies available for nylidrin and Dermatitis Medicamentosa

ArticleYear
Buphenin allergy.
    Contact dermatitis, 1984, Volume: 11, Issue:1

    Topics: Dermatitis, Contact; Drug Eruptions; Female; Humans; Middle Aged; Nylidrin

1984
Buphenine sensitivity.
    Contact dermatitis, 1984, Volume: 11, Issue:5

    Topics: Administration, Oral; Dermatitis, Contact; Drug Eruptions; Gels; Humans; Isoxsuprine; Male; Middle A

1984
[Generalized exanthematous pustulosis caused by buphenine: report of a case].
    Annales de dermatologie et de venereologie, 1992, Volume: 119, Issue:4

    Topics: Aged; Drug Eruptions; Female; Humans; Nylidrin; Skin Diseases, Vesiculobullous; Skin Tests

1992